CN100400067C - Dianduanxiang medicated liquor - Google Patents

Dianduanxiang medicated liquor Download PDF

Info

Publication number
CN100400067C
CN100400067C CNB2005101060655A CN200510106065A CN100400067C CN 100400067 C CN100400067 C CN 100400067C CN B2005101060655 A CNB2005101060655 A CN B2005101060655A CN 200510106065 A CN200510106065 A CN 200510106065A CN 100400067 C CN100400067 C CN 100400067C
Authority
CN
China
Prior art keywords
parts
radix
present
rheumatic
daphne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005101060655A
Other languages
Chinese (zh)
Other versions
CN1742884A (en
Inventor
蓝子花
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005101060655A priority Critical patent/CN100400067C/en
Publication of CN1742884A publication Critical patent/CN1742884A/en
Application granted granted Critical
Publication of CN100400067C publication Critical patent/CN100400067C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention discloses medicated liquor of Yunnan daphne, which is composed of yunnan daphne, glabrous gardneria root, buchanan cryptolepis root, Chinese atropanthe root, bittersweet herb and liquor (over 50 DEG) according to a certain proportion by weight. The present invention has the advantages of low cost, reasonable formula, simple preparation and convenient drinking; the medicines are combined to cause the efficiency of the medicines to generate synergistic functions; thereby, the present invention has outstanding curative effects on diseases such as rheumarthritis, traumatic injuries, rheumatic ostealgia, traumatic stasis swelling, arthragra, rheumatic numbness, rheumatic pain, rheumatic arthralgia and traumatic overstrain injuries. The present invention has the advantages of short therapeutic course and good therapeutic effect.

Description

A kind of Daphne feddei Levl. medicated wine
Technical field:
The present invention relates to a kind of Daphne feddei Levl. medicated wine.
Background technology:
Rheumatism, traumatic injury disease are a kind of common diseases, it is a lot of from ancient times to the present to suffer from the somebody, be subjected to ailing the torment deeply, the various medicine for external use of Xiao Shouing are also a lot of in the market, but no matter be Western medicine or Chinese medicine, slight illness for this class Drug therapy rheumatism, traumatic injury disease has played certain therapeutical effect really, but does not also have the specific drug of a kind of ideal treatment rheumatism, traumatic injury disease.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at pressing for of patient, eutherapeutic medicated wine; The inventor is through research repeatedly, and by clinical trial, checking repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, it is very convenient to drink, compare with existing similar medicated wine curative effect, better efficacy is the medicated wine of a kind of very ideal treatment rheumatism, traumatic injury disease.
Purpose of the present invention just provides a kind of Daphne feddei Levl. medicated wine.
Choice of drug Daphne feddei Levl. of the present invention, Radix Gardneriae angustifoliae, Radix Cryptolepis buchananii, Radix scopoliae sinensis, Herba Solani Lyrati, Chinese liquor (more than 50 degree) are formed; Wherein select Daphne feddei Levl. for use: have expelling wind and removing dampness, the pain relieving dissipating blood stasis; Treating rheumatic arthritis, traumatic injury.Select Radix Gardneriae angustifoliae for use: have dispelling, collateral-activating; The dispelling the wind and dampness pathogens osteodynia.Select Radix Cryptolepis buchananii for use: have relaxing muscles and tendons and activating QI and blood in the collateral, Repercusion analgesia; Treating rheumatic arthritis, traumatic injury.Select Radix scopoliae sinensis for use: have relaxing muscles and tendons and activating QI and blood in the collateral, eliminating stasis to stop pain; Dispelling the wind and dampness pathogens arthritis, traumatic injury.Select Herba Solani Lyrati for use: have dredge the meridian passage, invigorating blood circulation chases after wind; Dispelling the wind and dampness pathogens arthralgia.Make the effect of each medicine produce collaborative effect these drug regimens, thereby the curative effect of disease that can realize effectively treating rheumatic arthritis, traumatic injury, rheumatic ostalgia, traumatic injury congestive edema, arthragra, rheumatic numbness, rheumatalgia, Fengshi Guanjie pain, traumatic injury impairment caused by overstrain is definite, short treating period, curative effect is good.
The consumption of drug component of the present invention also is to put into practice in a large number to grope to sum up through the inventor to draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Daphne feddei Levl. 1-15 part, Radix Gardneriae angustifoliae 1-15 part, Radix Cryptolepis buchananii 1-14 part, Radix scopoliae sinensis 1-6 part, Herba Solani Lyrati 1-14 part, Chinese liquor (more than 50 degree) 20-288 part.
Optimization formula of the present invention is:
13 parts of Daphne feddei Levl.s, 13 parts of Radix Gardneriae angustifoliaes, 12 parts of Radix Cryptolepis buchananiis, 4 parts of Radix scopoliae sinensiss, 12 parts of Herba Solani Lyratis, 240 parts of Chinese liquor (more than 50 degree).
A kind of Daphne feddei Levl. medicated wine of the present invention has the effect of relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, expelling wind and removing dampness; Be applicable to the disease of treatment rheumatic arthritis, traumatic injury, rheumatic ostalgia, traumatic injury congestive edema, arthragra, rheumatic numbness, rheumatalgia, Fengshi Guanjie pain, traumatic injury impairment caused by overstrain; Be a kind of with low cost, prescription rationally, preparation is simple, it is very convenient to drink, and compares better efficacy with existing similar medicated wine curative effect.Daphne feddei Levl. medicated wine of the present invention was once done a large amount of clinical trials in early stage, given surplus the patient treatment case tens example time, comprise the disease that is used for the treatment of rheumatic arthritis, traumatic injury, rheumatic ostalgia, traumatic injury congestive edema, arthragra, rheumatic numbness, rheumatalgia, Fengshi Guanjie pain, traumatic injury impairment caused by overstrain, do not see untoward reaction during the treatment.Total effective rate is more than 76%, and the treatment works well.
Instructions of taking:
This medicated wine is drunk 2-3 time every day, drinks 20-100ml at every turn, is not taken by pregnant women.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Daphne feddei Levl. medicated wine provided by the present invention is made up of the component of following parts by weight; Daphne feddei Levl. 1-15 part, Radix Gardneriae angustifoliae 1-15 part, Radix Cryptolepis buchananii 1-14 part, Radix scopoliae sinensis 1-6 part, Herba Solani Lyrati 1-14 part, Chinese liquor (more than 50 degree) 20-288 part.
Embodiment 2:
Optimization formula of the present invention is:
13 parts of Daphne feddei Levl.s, 13 parts of Radix Gardneriae angustifoliaes, 12 parts of Radix Cryptolepis buchananiis, 4 parts of Radix scopoliae sinensiss, 12 parts of Herba Solani Lyratis, 240 parts of Chinese liquor (more than 50 degree).
Preparation method of the present invention is: at first with above-mentioned Daphne feddei Levl., Radix Gardneriae angustifoliae, Radix Cryptolepis buchananii, Radix scopoliae sinensis, Herba Solani Lyrati, single cutting into pieces respectively, with single cut into pieces to be mixed in proportion mix together evenly, be placed in the container then, and allocate an amount of Chinese liquor (50 degree more than) into, stir in the sealed container of back, according to the processing technology of modern Chinese medicine wine or soaked 7-15 days, the mixture solution (medicated wine) after handling is filtered, packing into by the required metering of client gets product in the bottle.

Claims (2)

1. Daphne feddei Levl. medicated wine, it is characterized in that: its raw material consists of by following parts by weight; 5 parts of Daphne feddei Levl. 1-1, Radix Gardneriae angustifoliae 1-15 part, Radix Cryptolepis buchananii 1-14 part, Radix scopoliae sinensis 1-6 part, Herba Solani Lyrati 1-14 part, the above 20-288 part of Chinese liquor 50 degree.
2. a kind of Daphne feddei Levl. medicated wine according to claim 1, it is characterized in that: its raw material consists of by following parts by weight; 13 parts of Daphne feddei Levl.s, 13 parts of Radix Gardneriae angustifoliaes, 12 parts of Radix Cryptolepis buchananiis, 4 parts of Radix scopoliae sinensiss, 12 parts of Herba Solani Lyratis, above 240 parts of Chinese liquor 50 degree.
CNB2005101060655A 2005-09-19 2005-09-19 Dianduanxiang medicated liquor Expired - Fee Related CN100400067C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005101060655A CN100400067C (en) 2005-09-19 2005-09-19 Dianduanxiang medicated liquor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005101060655A CN100400067C (en) 2005-09-19 2005-09-19 Dianduanxiang medicated liquor

Publications (2)

Publication Number Publication Date
CN1742884A CN1742884A (en) 2006-03-08
CN100400067C true CN100400067C (en) 2008-07-09

Family

ID=36138509

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005101060655A Expired - Fee Related CN100400067C (en) 2005-09-19 2005-09-19 Dianduanxiang medicated liquor

Country Status (1)

Country Link
CN (1) CN100400067C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI504394B (en) 2011-04-29 2015-10-21 Ind Tech Res Inst Method for preparing antofine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1286995A (en) * 2000-09-14 2001-03-14 李长富 Medicinal liquor with Chinese medicine for treating rheumatoid disease and its preparation
CN1294916A (en) * 2000-08-02 2001-05-16 张治东 Medicated wine for treating rheumatism and pain bones and muscles and its preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294916A (en) * 2000-08-02 2001-05-16 张治东 Medicated wine for treating rheumatism and pain bones and muscles and its preparation
CN1286995A (en) * 2000-09-14 2001-03-14 李长富 Medicinal liquor with Chinese medicine for treating rheumatoid disease and its preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
筋骨痛药酒方剂型改革探讨. 王燕,曹磊磊,沈郁.四川中医,第4期. 1988
筋骨痛药酒方剂型改革探讨. 王燕,曹磊磊,沈郁.四川中医,第4期. 1988 *

Also Published As

Publication number Publication date
CN1742884A (en) 2006-03-08

Similar Documents

Publication Publication Date Title
CN1329058C (en) Medicated liquor of cortex Zanthoxyli podocarpi
CN1329051C (en) Luoshiteng medicated liquor
CN1329048C (en) Compound lotus plumule oral liquor and preparing method thereof
CN100400071C (en) Wuxiangteng medicated liquor
CN100400067C (en) Dianduanxiang medicated liquor
CN1329054C (en) Lopseed-root medicated liquor
CN100420469C (en) Damp-repellent pain-relieving medicine liquor of caulis seu Radix Parabarii Micranthi
CN100558382C (en) A kind of damp-repellent pain-relieving medicine liquor of cortex zanthoxyli podocarpi
CN100346803C (en) Tiekuaizi medicated liquor
CN100400058C (en) Wuxiangxueteng medicated liquor
CN100400063C (en) Xiaolongguojiang medicated liquor
CN100420467C (en) Damp-repellent pain-relieving medicinal liquor of Radix hylomeconis
CN1329057C (en) Medicated liqor of Radix Oenotherae Erythrosepalae
CN100400057C (en) Xunmagen medicated liquor
CN100391516C (en) Shuihema medicated liquor
CN1329052C (en) Medicated lanceolarium Roxb medicated liquor
CN1329063C (en) Medicated liquor of stephania japonica miers
CN100420475C (en) Damp-repellent pain-relieving medicinal liquor of Rhizoma et Radix caulophy lei
CN100551407C (en) A kind of medicated wine for the treatment of the traumatic injury disease
CN100536903C (en) Damp-repellent pain-relieving medicinal liquor of Radix Vaccinii Fragilis
CN100400061C (en) Damp-repellent pain-relieving medicinal liquor of Herba Asplenii Trichomanis
CN100342886C (en) Medicated liquor of Radix elsholtziae Fruticosae
CN1329074C (en) Pandanguo medicated liquor
CN100551419C (en) A kind of medicated wine for the treatment of the traumatic injury disease
CN100420466C (en) Fracture-treating medicated liquor of Herba seu Radix peperomiae Tetraphyllate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080709

Termination date: 20091019